Last reviewed · How we verify
tTF-NGR
At a glance
| Generic name | tTF-NGR |
|---|---|
| Also known as | truncated tissue factor (tTF)-NGR |
| Sponsor | Universität Münster |
| Modality | Biologic |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- tTF-NGR Randomized Study - STS (PHASE3)
- tTF-NGR Phase I Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tTF-NGR CI brief — competitive landscape report
- tTF-NGR updates RSS · CI watch RSS
- Universität Münster portfolio CI